Method for the production of an Nterminally modified chemotactic factor

Details for Australian Patent Application No. 2004233964 (hide)

Owner Boehringer Ingelheim International GmbH Boehringer Ingelheim International GmbH

Inventors Doods, Henri; Necina, Roman; Wandl, Robert; Lenter, Martin; Seidler, Randolph

Agent Davies Collison Cave

Pub. Number AU-A-2004233964

PCT Pub. Number WO2004/096850

Priority 03010014.3 02.05.03 EP

Filing date 13 April 2004

Wipo publication date 11 November 2004

International Classifications

A61P 009/00 Drugs for disorders of the cardiovascular system

A61K 038/19 Medicinal preparations containing peptides - Cytokines

C12N 015/19 Mutation or genetic engineering - Interferons

C07K 014/52 Peptides having more than 20 amino acids

Event Publications

8 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096850 Priority application(s): WO2004/096850

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233966-Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2

2004233961-Stabiliser system for the stabilisation of halogenated polymers